正在加载视频...
视频加载失败
DeSci isn’t about DISRUPTING science; it’s about ACCELERATING it. From funding biotech IP to real clinical trials, Bio Protocol is building for the long term. Paul Kohlhaas bio/acc explains why real-world assets matter more than hype cycles. Watch his full interview with Jorge | The Gaming Strategist below 👇
34,166 次观看 • 7 个月前 •via X (Twitter)
0 条评论
暂无评论
原始帖子的评论将显示在这里



